mTOR pathway (original) (raw)

Cancer Treatment Reviews, 2004

View PDFchevron_right

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Carlos Castañeda

Cancer and Metastasis Reviews, 2010

View PDFchevron_right

The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications

Alexandre Arcaro

Current Genomics, 2007

View PDFchevron_right

Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216

Jinjiang Zhu

Clinical Cancer Research, 2014

View PDFchevron_right

Activation of PI3Kα by physiological effectors and by oncogenic mutations: structural and dynamic effects

Sandra Gabelli

Biophysical Reviews, 2014

View PDFchevron_right

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

C. Fumarola

Biochemical Pharmacology, 2014

View PDFchevron_right

A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain

Anke Klippel

Molecular and cellular biology, 1997

View PDFchevron_right

PIK3CA Cooperates with Other Phosphatidylinositol 3'-Kinase Pathway Mutations to Effect Oncogenic Transformation

David Stokoe

Cancer Research, 2008

View PDFchevron_right

The PKB/AKT Pathway in Cancer

Amancio Carnero

Current Pharmaceutical Design, 2010

View PDFchevron_right

Targeting PI3K in Cancer: Any Good News?

Miriam Martini

Frontiers in Oncology, 2013

View PDFchevron_right

Status of PI3K inhibition and biomarker development in cancer therapeutics

Josep Tabernero

Annals of …, 2010

View PDFchevron_right

Analysis of PI3K pathway components in human cancers

Bashar Saad

Oncology Letters, 2016

View PDFchevron_right

Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases

Alan Henley

Cancer Research, 2007

View PDFchevron_right

Cancer Therapy : Preclinical Antitumor Efficacy of PKI-587 , a Highly Potent Dual PI 3 K / mTOR Kinase Inhibitor

Inder Chaudhary

2011

View PDFchevron_right

Inhibiting PI3K as a therapeutic strategy against cancer

Luis Paz-ares, Amancio Carnero

Clinical and Translational Oncology, 2009

View PDFchevron_right

Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor

Semiramis Ayral-Kaloustian

Clinical Cancer …, 2011

View PDFchevron_right

Potential of PI3Kβ Inhibitors in the Treatment of Cancer and Other Diseases

Ahmed Abdel-Magid

ACS medicinal chemistry letters, 2017

View PDFchevron_right

Targeting phosphoinositide 3-kinase—Moving towards therapy

Bernd Giese, Vladimir Cmiljanovic

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008

View PDFchevron_right

3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma

Lao Saal

Cancer Research, 2009

View PDFchevron_right

The selective PI3K inhibitor XL147 (SAR245408) inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models

Wendy Abulafia, Paul Keast, Sanh Lam, Charles Marlowe

Molecular cancer therapeutics, 2015

View PDFchevron_right

Oncogenic PI3K deregulates transcription and translation

Peter Vogt

Nature Reviews Cancer, 2005

View PDFchevron_right

Characterization of the Activity of the PI3K/mTOR Inhibitor XL765 (SAR245409) in Tumor Models with Diverse Genetic Alterations Affecting the PI3K Pathway

Xiangnan Du

Molecular Cancer Therapeutics, 2014

View PDFchevron_right

Targeting PI3K/Akt/mTOR Signaling in Cancer

Alessandra Mosca

Frontiers in oncology, 2014

View PDFchevron_right

DEVELOPMENT OF DRUGS TARGETING THE PI3K SIGNALLING PATHWAY IN LEUKAEMIAS AND LYMPHOMAS

Alexandre Arcaro

View PDFchevron_right

PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches

Linda Steelman

Cell Cycle, 2009

View PDFchevron_right

Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets

Alexandre Arcaro

Current Drug Targets, 2011

View PDFchevron_right

Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway (original) (raw)

Related papers